Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

The projected decline in Metropolis Healthcare Limited's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 0.000000
forwardPE 38.243095
debtToEquity 13.916000
earningsGrowth 0.304000
revenueGrowth 0.258000
grossMargins 0.775390
operatingMargins 0.155130
trailingEps 8.080000
forwardEps 12.213970

Metropolis Healthcare Limited's low Debt-to-Equity ratio reflects that the company isn't heavily reliant on debt, reducing financial risk. This conservative approach suggests Metropolis Healthcare Limited maintains a stable financial foundation, with greater flexibility to manage future growth or challenges without over-leverage concerns.
Positive earnings and revenue growth for METROPOLIS suggest that the company is positioned for business expansion. The company's strong financial performance indicates sustained growth, as increasing sales and profits fuel its future success.
METROPOLIS's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with METROPOLIS anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

METROPOLIS's price projections have been gradually revised upward, reflecting increased confidence in the company's future performance. This trend suggests analysts expect METROPOLIS to achieve greater success in the coming periods.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


The recent buy bias for Metropolis Healthcare Limited from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see Metropolis Healthcare Limited as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.